Idoven, a Madrid, Spain-based provider of an AI cardiology-as-a-service platform, raised an undisclosed amount in new funding.
The round was led by Northzone and Insight Partners. Pau Gasol, a Hall of Famer and two-time NBA Champion with the Los Angeles Lakers, became an investor in the company, through Gasol16 Ventures. Additional investors included Hambro Perks as well Spring Health co-founder, Adam Chekroud, and Carto CEO, Luis Sanz.
The company intends to use the funds to accelerate the rollout of new solutions using its core technology, support healthcare professionals to accurately and efficiently diagnose cardiovascular diseases, and further its geographic expansion.
Led by Manuel Marina Breysse, cardiologist, CEO, Idoven has developed an AI cardiology-as-a-service platform that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale. The technology evolved from a desktop software created in Madrid in 2018 to a cloud-based AI solution used by medical device manufacturers and pharmaceutical companies around the world. To achieve this growth, Idoven has moved from a closed platform to an open one that can be integrated with third-party hardware, software, electronic medical record systems and pharma companies’ digital solutions.
The company counts global organizations such as AstraZeneca, Abbott, GE Healthcare, FIFPRO, Google, Santander, and Real Madrid Foundation as partners.
Commenting on the investment, Pau Gasol said: “As a former elite athlete, I know firsthand how important early detection and prevention can be to maintaining optimal health, especially when it comes to cardiovascular issues. I am thrilled to contribute with my expertise and knowledge, building a strong and successful team culture in a company which has the potential to save thousands of lives, as well as my network and reach to help Idoven scale at such a crucial phase of its growth. Idoven’s AI technology is completely changing how we measure a healthy heart and prevent and treat heart related disease, something I think will make a big difference.”
Spanish World Cup-winning goalkeeper Iker Casillas invested in the seed round of the company after suffering a heart attack in training at the age of 37.
FinSMEs
05/09/2023